Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Nichols

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Immunology|June 1, 1983
A monoclonal antibody (100C5) to the Lyt-2-T cell population expanding in MRL/Mp-lpr/lpr mice detects a surface antigen normally expressed on Lyt-2+ cells and B cellsF J Dumont, R C Habbersett, E A Nichols, et al.
European Journal of Immunology|October 11, 1990
Suppression of B cell activation by cyclosporin A, FK506 and rapamycinL S Wicker, R C Boltz, V Matt, et al.
Cellular Immunology|May 1, 1987
Large, activated B cells are the primary B-cell target of 8-bromoguanosine and 8-mercaptoguanosineL S Wicker, R C Boltz, E A Nichols, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401C M Hill, A Liu, K W Marshall, et al.
Cellular Immunology|March 1, 1988
5-Halo-6-phenyl pyrimidinones and 8-substituted guanosines: biological response modifiers with similar effects on B cellsL S Wicker, W T Ashton, R C Boltz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Immunology|June 1, 1983
A monoclonal antibody (100C5) to the Lyt-2-T cell population expanding in MRL/Mp-lpr/lpr mice detects a surface antigen normally expressed on Lyt-2+ cells and B cellsF J Dumont, R C Habbersett, E A Nichols, et al.
European Journal of Immunology|October 11, 1990
Suppression of B cell activation by cyclosporin A, FK506 and rapamycinL S Wicker, R C Boltz, V Matt, et al.
Cellular Immunology|May 1, 1987
Large, activated B cells are the primary B-cell target of 8-bromoguanosine and 8-mercaptoguanosineL S Wicker, R C Boltz, E A Nichols, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401C M Hill, A Liu, K W Marshall, et al.
Cellular Immunology|March 1, 1988
5-Halo-6-phenyl pyrimidinones and 8-substituted guanosines: biological response modifiers with similar effects on B cellsL S Wicker, W T Ashton, R C Boltz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Pageof 2